Popular Arthritis Drugs Less Cost-Effective Than Common Pain Killers

Selective COX-2 inhibitors, such as rofecoxib (Vioxx) and celecoxib (Celebrex), are not as cost-effective as common non-steroidal anti-inflammatory drugs, such as ibuprofen (Motrin, Advil, Nuprin), indomethacin, and naproxen, in treating arthritis in the average patient. This was the conclusion of a recent study conducted by the University of California (Los Angeles) and the Veterans Affairs of Greater Los Angeles. Researchers found that the newer COX-2 drugs, developed to offer the same pain relief as NSAIDs but…
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access